Tectonic Therapeutic Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tectonic Therapeutic (TECX).

Price Target Range — 10 Quarters

Analyst Consensus — 11 Analysts

1S.Buy

9Buy

1Hold

Consensus RatingOutperform# Analysts11Avg. Consensus PT$72Upside to Avg. PT+250.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	UBS	Alice Nettleton	Initiate	Neutral	$26
Aug 7, 2026	Wells Fargo	Tiago Fauth	PT Cut	Overweight	$101→$93
May 26, 2026	Raymond James	Michael Freeman	Upgrade	Outperform→Strong Buy	$76→$81
Apr 14, 2026	Stifel	James Condulis	Initiate	Buy	$75
Jan 8, 2026	Truist Securities	Danielle Brill	PT Cut	Buy	$64→$60
Sep 3, 2025	Oppenheimer	Leland Gershell	Initiate	Outperform	$80
Jul 21, 2025	Truist Securities	Danielle Brill	Initiate	Buy	$64
Jun 11, 2025	Raymond James	Michael Freeman	Reinstates	Outperform	$76
Jun 6, 2025	LifeSci Capital	—	Initiate	Outperform	$87
May 15, 2025	Mizuho	Uy Ear	PT Raise	Outperform	$51→$85
Apr 21, 2025	Mizuho	Uy Ear	Initiate	Outperform	$51
Mar 21, 2025	Wells Fargo	Tiago Fauth	PT Cut	Overweight	$112→$101
Jan 31, 2025	Wells Fargo	Tiago Fauth	PT Raise	Overweight	$79→$112
Nov 20, 2024	Raymond James	Danielle Brill	Initiate	Outperform	$65
Nov 12, 2024	Wells Fargo	Tiago Fauth	PT Raise	Overweight	$55→$79
Nov 11, 2024	Leerink Partners	David Risinger	PT Raise	Outperform	$49→$69
Aug 22, 2024	Wells Fargo	Tiago Fauth	Initiate	Overweight	$55
Jul 24, 2024	Leerink Partners	David Risinger	Initiate	Outperform	$49
Jun 26, 2024	Piper Sandler	Yasmeen Rahimi	Initiate	Overweight	$76
Jun 24, 2024	TD Cowen	Tyler Van Buren	Initiate	Buy	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26

UBS analyst Alice Nettleton initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Neutral rating and announces Price Target of $26.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target from $101 to $93.

Benzinga Newsdesk

PRO
Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform to Strong Buy and raises the price target from $76 to $81.

Benzinga Newsdesk

PRO
Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $75.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

Truist Securities analyst Danielle Brill maintains Tectonic Therapeutic (NASDAQ:TECX) with a Buy and lowers the price target from $64 to $60.

Benzinga Newsdesk

PRO
Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80

Oppenheimer analyst Leland Gershell initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform rating and announces Price Target of $80.

Benzinga Newsdesk

Tectonic Therapeutic Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Tectonic Therapeutic Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
UBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26

PRO
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

PRO
Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

PRO
Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

PRO
Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

PRO
Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80

People Also Watch

People Also Watch

Tectonic Therapeutic Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Tectonic Therapeutic Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROUBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26

PROWells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

PRORaymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

PROStifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

PROTruist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

PROOppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80

People Also Watch

People Also Watch

PRO
UBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26

PRO
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

PRO
Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

PRO
Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

PRO
Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

PRO
Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80